Read the corresponding article: https://peptideresearch.us/advanced-fat-metabolism-research-stacking-retatrutide-and-aod-9604/

Join the Insider Club for Wholesale Peptides: https://wholesalepeptides.us/insider-club/

Click here to join our Discord: Real Peptide Talk

Shop Research Compounds: https://wholesalepeptides.us

Visit our blog: https://peptideresearch.us

Join our Newsletter list: https://peptideresearch.us/newsletter

In this episode of The Peptide Research Podcast, we dive into the cutting-edge science of advanced fat metabolism research, focusing on the highly discussed strategy of stacking Retatrutide and AOD-9604.

We break down how researchers are studying this powerful combination to target multi-pathway weight management. The episode explores Retatrutide's unique triple-agonist mechanism (targeting GLP-1, GIP, and glucagon receptors) alongside AOD-9604’s specific lipolytic (fat-burning) properties that avoid affecting blood sugar or IGF-1 levels. We discuss the theoretical synergy of combining these two compounds, current preclinical insights on metabolic efficiency, and critical considerations regarding research protocols, side effects, and experimental outcomes.

If you have been curious about how the next generation of metabolic research compounds work and why stacking Retatrutide and AOD-9604 is drawing massive interest in the scientific community, this episode provides a clear, evidence-based overview of the current landscape.